Abstract

Sterols are constituents of the cellular membranes that are essential for their normal structure and function. In mammalian cells, cholesterol is the main sterol found in the various membranes. However, other sterols predominate in eukaryotic microorganisms such as fungi and protozoa. It is now well established that an important metabolic pathway in fungi and in members of the Trypanosomatidae family is one that produces a special class of sterols, including ergosterol, and other 24-methyl sterols, which are required for parasitic growth and viability, but are absent from mammalian host cells. Currently, there are several drugs that interfere with sterol biosynthesis (SB) that are in use to treat diseases such as high cholesterol in humans and fungal infections. In this review, we analyze the effects of drugs such as (a) statins, which act on the mevalonate pathway by inhibiting HMG-CoA reductase, (b) bisphosphonates, which interfere with the isoprenoid pathway in the step catalyzed by farnesyl diphosphate synthase, (c) zaragozic acids and quinuclidines, inhibitors of squalene synthase (SQS), which catalyzes the first committed step in sterol biosynthesis, (d) allylamines, inhibitors of squalene epoxidase, (e) azoles, which inhibit C14α-demethylase, and (f) azasterols, which inhibit Δ24(25)-sterol methyltransferase (SMT). Inhibition of this last step appears to have high selectivity for fungi and trypanosomatids, since this enzyme is not found in mammalian cells. We review here the IC50 values of these various inhibitors, their effects on the growth of trypanosomatids (both in axenic cultures and in cell cultures), and their effects on protozoan structural organization (as evaluted by light and electron microscopy) and lipid composition. The results show that the mitochondrial membrane as well as the membrane lining the protozoan cell body and flagellum are the main targets. Probably as a consequence of these primary effects, other important changes take place in the organization of the kinetoplast DNA network and on the protozoan cell cycle. In addition, apoptosis-like and autophagic processes induced by several of the inhibitors tested led to parasite death.

Highlights

  • Sterols are constituents of the cellular membranes that are essential for their normal structure and function

  • When the first biochemical analysis of lower trypanosomatids grown in chemically defined medium was carried out, it became clear that they synthesize ergosterol and not cholesterol [1]

  • The last class of ergosterol biosynthesis inhibitors comprises the azasterols, which inhibit Δ24(25)-sterol methyltransferase (SMT). Inhibition of this step appears to have high selectivity for fungi and trypanosomatids since this enzyme is not found in mammalian cells

Read more

Summary

Introduction

Sterols are constituents of the cellular membranes that are essential for their normal structure and function. At least 20 metabolic steps are necessary to synthesize such sterols as cholesterol and ergosterol, with some steps involving specific enzymes that differ between mammalian cells and microorganisms such as fungi and trypanosomatids. The two reactions comprise the first committed step in sterol biosynthesis These are catalyzed by the enzyme squalene synthase, which promotes a head-to-head condensation of two molecules of farnesyl diphosphate to produce squalene. Removal of the 14α-methyl by C14α-demethylase generates a Δ8(14) unsaturated sterol with a double bond at the C14 position This unsaturation needs to be removed to produce Δ5 sterols in two consecutive reactions catalyzed by the enzyme Δ8(14)-reductase with NADPH as cofactor. Immunofluorescence and electron microscopic observations using antibodies generated against the recombinant protein showed that 24-SMT is located in the endoplasmic reticulum and in translucent vesicles that presumably belong to the endocytic pathway [47]

Available Drugs that Interfere with the Sterol Biosynthetic Pathway
Effects of SB Inhibitors on Trypanosomatid Growth
Effects of SB Inhibitors on the Ultrastructure of Trypanosomatids
Effects of SB Inhibitors on Lipid Composition
Findings
Perspectives
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call